Skip to main content
ARS Home » Southeast Area » Athens, Georgia » U.S. National Poultry Research Center » Toxicology & Mycotoxin Research » Research » Publications at this Location » Publication #272340
Title: Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydro-sphingosine 1-phosphate in human neural progenitor cells

Author
item CALLIHAN, PHILLIP - University Of Georgia
item ZITOMER, NICHOLAS - Centers For Disease Control And Prevention (CDC) - United States
item STOELING, MICHAEL - University Of Georgia
item KENNEDY, PERRY - University Of Virginia
item LYNCH, KEVIN - University Of Virginia
item Riley, Ronald
item HOOKS, SHELLEY - University Of Georgia

Submitted to: Neuropharmacology
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: 10/1/2011
Publication Date: 3/1/2012
Citation: Callihan, P., Zitomer, N., Stoeling, M., Kennedy, P., Lynch, K.R., Riley, R.T., Hooks, S.B. 2012. Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydro-sphingosine 1-phosphate in human neural progenitor cells. Neuropharmacology. 62:988-996.

Interpretive Summary: Sphingosine 1-phosphate (S1P) is a fat that is produced in cells in response to specific stimuli. It belongs to a group of fats known as sphingolipids. When S1P is produced it can bind to proteins on the outside of cells which are known as S1P receptors. The binding of S1P to its receptors is critical for the development of the nervous system. The chemical known as dihydrosphingosine 1-phosphate (dhS1P) also binds to S1P receptors, but the pharmacology and physiology of dhS1P has not been widely studied. Fumonisin B1 is a chemical produced by a fungus that is a common contaminant of corn. Fumonisin B1 blocks the ability of the enzyme known as ceramide synthase to make ceramide and causes the selective accumulation of dihydrosphingosine and dhS1P. Recent studies suggest that maternal exposure to FB1 is correlated with the development of neural tube defects (NTDs) in which the neural epithelial progenitor cells of the developing brain fail to fuse. We hypothesize that altered signaling by S1P and dhS1P in neural epithelial cells contributes to the developmental effects of FB1. The goal of this work was to first define the effect of FB1 exposure on sphingosine and dh-sphingosine levels and their receptor active 1-phosphate derivatives in human embryonic stem cell-derived neural epithelial progenitor (hES-NEP) cells; and second, to define the relative activity of dhS1P and S1P in hES-NEP cells. We found that dhS1P is better at blocking the addition of phosphate to specific proteins in neural progenitors, and this difference in apparent potency may be due to more persistent presence of extracellular dh-S1P applied to human neural progenitors rather than a higher activity at S1P receptors. This study establishes hES-NEP cells as a useful human in vitro model system to study the mechanism of FB1 developmental toxicity.

Technical Abstract: In-vivo and in-vitro studies suggest a crucial role for Sphingosine 1-phosphate (S1P) and its receptors in the development of the nervous system. Dihydrosphingosine 1-phosphate (dhS1P), a reduced form of S1P, is an active ligand at S1P receptors, but the pharmacology and physiology of dhS1P has not been widely studied. The mycotoxin fumonisin B1(FB1) is a potent inhibitor of the enzyme ceramide synthase and causes selective accumulation of dihydrosphingosine and dhS1P. Recent studies suggest that maternal exposure to FB1 is correlated with the development of neural tube defects (NTDs) in which the neural epithelial progenitor cells of the developing brain fail to fuse. We hypothesize that altered signaling by S1P and dhS1P in neural epithelial cells contributes to the developmental effects of FB1. The goal of this work was to first define the effect of FB1 exposure on levels of sphingosine and dh-sphingosine levels and their receptor active 1-phosphate derivatives in human embryonic stem cell-derived neural epithelial progenitor (hES-NEP) cells; and second, to define the relative activity of dhS1P and S1P in hES-NEP cells. Specifically, dhS1P is a more potent stimulator of inhibition of cAMP and Smad phosphorylation than is S1P in neural progenitors, and this difference in apparent potency may be due to more persistent presence of extracellular dh-S1P applied to human neural progenitors rather than a higher activity at S1P receptors. This study establishes hES-NEP cells as a useful human in vitro model system to study the mechanism of FB1 toxicity and the molecular pharmacology of sphingolipid signaling cascades.